These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1362275)

  • 1. Biologic, pharmacologic, and psychosocial factors influencing response to neuroleptics.
    Kane JM
    Psychopharmacol Bull; 1992; 28(3):227-9. PubMed ID: 1362275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.
    Wiesel FA
    Br J Psychiatry Suppl; 1994 Apr; (23):65-70. PubMed ID: 7913610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of neuroleptics in a attempt at understanding the vulnerability to schizophrenia].
    Meurice E
    Acta Psychiatr Belg; 1992; 92(6):339-54. PubMed ID: 1364282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Delayed-action neuroleptics and maintenance treatments].
    Péron-Magnan P
    Encephale; 1991; 17(4):263-6. PubMed ID: 1683627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depot neuroleptics: the relevance of psychosocial factors--a United States perspective.
    Hogarty GE
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):36-42. PubMed ID: 6143746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incidence of the deficit form in refractory schizophrenia].
    Samuelian JC
    Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depot neuroleptic therapy: clinical considerations.
    Remington GJ; Adams ME
    Can J Psychiatry; 1995 Apr; 40(3 Suppl 1):S5-11. PubMed ID: 7627927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic-resistant schizophrenia treated with clozapine and ECT.
    Benatov R; Sirota P; Megged S
    Convuls Ther; 1996 Jun; 12(2):117-21. PubMed ID: 8744173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schizophrenia.
    Marder SR; Ames D; Wirshing WC; Van Putten T
    Psychiatr Clin North Am; 1993 Sep; 16(3):567-87. PubMed ID: 8105452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug abuse experience and neuroleptic prescriptions at the onset of schizophrenia].
    Lisoprawski A
    Sem Hop; 1983 Jun; 59(25):1925-7. PubMed ID: 6136096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-reported prescribing practices for schizophrenic patients among Israeli psychiatrists.
    Heresco-Levy U; Brom D; Greenberg D
    Isr J Psychiatry Relat Sci; 1993; 30(3):164-74. PubMed ID: 7901179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of neuroleptic medications on the cognition of patients with schizophrenia: a review of recent studies.
    Goldberg TE; Weinberger DR
    J Clin Psychiatry; 1996; 57 Suppl 9():62-5. PubMed ID: 8823353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of the adjuvant use of benzodiazepines for treating outpatients with schizophrenia.
    Pecknold JC
    J Psychiatry Neurosci; 1993 Mar; 18(2):82-4. PubMed ID: 8096393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia.
    Meltzer HY; Sommers AA; Luchins DJ
    J Clin Psychopharmacol; 1986 Dec; 6(6):329-38. PubMed ID: 2879856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Profile of the action of neuroleptics in deficit schizophrenia].
    Vanelle JM
    Encephale; 1996 Jun; 22 Spec No 2():33-9. PubMed ID: 8767040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia.
    Lieberman JA; Koreen AR; Chakos M; Sheitman B; Woerner M; Alvir JM; Bilder R
    J Clin Psychiatry; 1996; 57 Suppl 9():5-9. PubMed ID: 8823344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation trial on the efficacy of neuroleptics on the outcome of schizophrenia].
    Dollfus S; Petit M
    Encephale; 1991; 17(4):247-53. PubMed ID: 1683625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Creativity and antipsychotic drugs].
    Murry P; Torrecuadrada JL
    Encephale; 1997 Sep; 23 Spec No 4():17-9. PubMed ID: 9417399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment refractory schizophrenia].
    Vanelle JM
    Encephale; 1995 Jun; 21 Spec No 3():13-21. PubMed ID: 7628336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Education groups in neuroleptic treatment of schizophrenic patients].
    Gaillard P; Degiovanni A; Parrot F
    Ann Med Psychol (Paris); 1993 Apr; 151(4):340-2. PubMed ID: 7904433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.